French biopharma Ipsen and US-based Marengo Therapeutics have formed a strategic partnership that aims to advance two of Marengo’s preclinical immuno-oncology candidates...
The pharma industry’s poaching season is on, though some say it’s never off, just taking a break. In the latest drugmaker-to-drugmaker side-swap, among the top news this...
Loxo Oncology at Lilly and Foghorn Therapeutics are collaborating to create novel oncology medicines based on the latter’s Gene Traffic Control platform. Under the terms...
French drugmaker Sanofi is taking an equity stake worth $180 million in and entering a new strategic collaboration with artificial intelligence (AI) and precision...
15.03.2018
- US-based Kite Pharma, part of Gilead Sciences since October 2017, is collaborating with Sangamo Therapeutics to develop next-generation engineered cell therapies to treat cancer...
20.02.2018
- US Cullinan Oncology, based in Cambridge, MA, and German MAB Discovery (MABD) announced the initiation of a collaboration to develop novel antibody therapeutics based on MABD's...
12.01.2018
- A management reshuffle at the UK’s largest drugmaker, GlaxoSmithKline has caught the market’s attention, especially as it was carried through by closely watched CEO Emma Walmsley...
04.01.2018
- Roche is planning to buy US group Ignyta for around $1.7 billion in an all-cash deal that will expand the Swiss group’s portfolio of cancer medicines. San Diego, California-based...
